LncRNA TTN-AS1 intensifies sorafenib resistance in hepatocellular carcinoma by sponging miR-16-5p and upregulation of cyclin E1
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
LncRNA TTN-AS1 intensifies sorafenib resistance in hepatocellular carcinoma by sponging miR-16-5p and upregulation of cyclin E1
Authors
Keywords
Hepatocellular carcinoma, lncRNA TTN-AS1, Sorafenib, miR-16-5p, Resistance
Journal
BIOMEDICINE & PHARMACOTHERAPY
Volume 133, Issue -, Pages 111030
Publisher
Elsevier BV
Online
2020-11-28
DOI
10.1016/j.biopha.2020.111030
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Long non‐coding RNA TTN‐AS1 facilitates tumorigenesis of papillary thyroid cancer through modulating the miR‐153‐3p/ZNRF2 axis
- (2019) Zhenghui Cui et al. JOURNAL OF GENE MEDICINE
- Epigenetic Regulation of UDP-Glucuronosyltransferase by microRNA-200a/-183: Implications for Responses to Sorafenib Treatment in Patients with Hepatocellular Carcinoma
- (2019) Yang Ge et al. CANCER LETTERS
- LATS2 overexpression attenuates the therapeutic resistance of liver cancer HepG2 cells to sorafenib-mediated death via inhibiting the AMPK–Mfn2 signaling pathway
- (2019) Jie Song et al. Cancer Cell International
- Long non-coding RNA AGAP2-AS1, functioning as a competitive endogenous RNA, upregulates ANXA11 expression by sponging miR-16-5p and promotes proliferation and metastasis in hepatocellular carcinoma
- (2019) Zhikui Liu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- LncRNA SNHG1 contributes to sorafenib resistance by activating the Akt pathway and is positively regulated by miR-21 in hepatocellular carcinoma cells
- (2019) Weidong Li et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Long non-coding RNA TTN-AS1 promotes the progression of lung adenocarcinoma by regulating PTEN/PI3K/AKT signaling pathway
- (2019) Jiwen Luo et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Inhibition of cyclin E1 sensitizes hepatocellular carcinoma cells to regorafenib by mcl-1 suppression
- (2019) Jianliang Xu et al. Cell Communication and Signaling
- LncRNA TTN-AS1 promotes migration, invasion, and epithelial mesenchymal transition of lung adenocarcinoma via sponging miR-142-5p to regulate CDK5
- (2019) Yunlong Jia et al. Cell Death & Disease
- Surgical and oncological outcomes of hepatic resection for BCLC-B hepatocellular carcinoma: a retrospective multicenter analysis among 474 consecutive cases
- (2019) Stefano Di Sandro et al. Updates in Surgery
- LncRNA TTN-AS1 regulates osteosarcoma cell apoptosis and drug resistance via the miR-134-5p/MBTD1 axis
- (2019) Dong Fu et al. Aging-US
- lncRNAs: function and mechanism in cartilage development, degeneration, and regeneration
- (2019) Jian Zhu et al. Stem Cell Research & Therapy
- Long non-coding RNA SSTR5-AS1 facilitates gemcitabine resistance via stabilizing NONO in gallbladder carcinoma
- (2019) Zhuowei Xue et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The implication of LncRNA MALAT1 in promoting chemo‐resistance of laryngeal squamous cell carcinoma cells
- (2019) Qining Jiang et al. JOURNAL OF CLINICAL LABORATORY ANALYSIS
- Knockdown Of lncRNA NCK-AS1 Regulates Cisplatin Resistance Through Modulating miR-137 In Osteosarcoma Cells
- (2019) Yi Cheng et al. OncoTargets and Therapy
- Long non-coding RNA TTN-AS1 promotes cell growth and metastasis in cervical cancer via miR-573/E2F3
- (2018) Ping Chen et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Antitumor and immunomodulatory activities of total flavonoids extract from persimmon leaves in H22 liver tumor-bearing mice
- (2018) Li Chen et al. Scientific Reports
- Starting Dose of Sorafenib for the Treatment of Hepatocellular Carcinoma: A Retrospective, Multi-Institutional Study
- (2017) Kim A. Reiss et al. JOURNAL OF CLINICAL ONCOLOGY
- AKR1B1 promotes basal-like breast cancer progression by a positive feedback loop that activates the EMT program
- (2017) Xuebiao Wu et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Long non-coding RNAs in hepatocellular carcinoma: Potential roles and clinical implications
- (2017) Zhao-Shan Niu et al. WORLD JOURNAL OF GASTROENTEROLOGY
- In silico and in vitro identification of inhibitory activities of sorafenib on histone deacetylases in hepatocellular carcinoma cells
- (2017) Tsang-Pai Liu et al. Oncotarget
- Expression of Concern: The functional role of long non-coding RNAs and epigenetics
- (2016) Shulin Li BIOLOGICAL PROCEDURES ONLINE
- Comprehensive characterization of the patient-derived xenograft and the paralleled primary hepatocellular carcinoma cell line
- (2016) Phyllis F. Y. Cheung et al. Cancer Cell International
- Aberrant JMJD3 Expression Upregulates Slug to Promote Migration, Invasion, and Stem Cell–Like Behaviors in Hepatocellular Carcinoma
- (2016) Bo Tang et al. CANCER RESEARCH
- Long non-coding RNAs as novel targets for therapy in hepatocellular carcinoma
- (2016) Mansi A. Parasramka et al. PHARMACOLOGY & THERAPEUTICS
- miR-372 suppresses tumour proliferation and invasion by targeting IGF2BP1 in renal cell carcinoma
- (2015) Xuan Huang et al. CELL PROLIFERATION
- Cyclin E1 Inhibition can Overcome Sorafenib Resistance in Hepatocellular Carcinoma Cells Through Mcl-1 Suppression
- (2015) C. Hsu et al. CLINICAL CANCER RESEARCH
- MicroRNA-519a promotes tumor growth by targeting PTEN/PI3K/AKT signaling in hepatocellular carcinoma
- (2015) KANGSHENG TU et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- The functional role of long non-coding RNAs and epigenetics
- (2014) Jinneng Cao BIOLOGICAL PROCEDURES ONLINE
- Long non-coding RNA: a new player in cancer
- (2013) Hua Zhang et al. Journal of Hematology & Oncology
- Major achievements in hepatocellular carcinoma
- (2009) Jordi Bruix et al. LANCET
- Expression of X-linked inhibitor-of-apoptosis protein in hepatocellular carcinoma promotes metastasis and tumor recurrence
- (2008) Ying-Hong Shi et al. HEPATOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started